These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21840276)

  • 1. Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c.
    Parchman ML; Wang CP
    Prim Care Diabetes; 2012 Apr; 6(1):19-25. PubMed ID: 21840276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.
    Cook MN; Girman CJ; Stein PP; Alexander CM; Holman RR
    Diabetes Care; 2005 May; 28(5):995-1000. PubMed ID: 15855556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
    Lipska KJ; Yao X; Herrin J; McCoy RG; Ross JS; Steinman MA; Inzucchi SE; Gill TM; Krumholz HM; Shah ND
    Diabetes Care; 2017 Apr; 40(4):468-475. PubMed ID: 27659408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding glucose-lowering agents delays insulin initiation and prolongs hyperglycemia.
    Hugie C; Waterbury NV; Alexander B; Shaw RF; Egge JA
    Am J Manag Care; 2016 Apr; 22(4):e134-40. PubMed ID: 27143349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
    Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
    BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.
    Derosa G; Mereu R; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    J Clin Pharm Ther; 2010 Oct; 35(5):565-79. PubMed ID: 20831680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
    Su JB; Wang XQ; Chen JF; Wu G; Jin Y
    Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
    Riedel AA; Heien H; Wogen J; Plauschinat CA
    Am J Manag Care; 2007 Aug; 13(8):457-63. PubMed ID: 17685826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
    Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
    Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diabetes mellitus: implications of the use of oral agents.
    Rao SV; Bethel MA; Feinglos MN
    Am Heart J; 1999 Nov; 138(5 Pt 1):S334-7. PubMed ID: 10539794
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal change in HbA1c after insulin initiation in primary care patients with type 2 diabetes: a database analysis in UK and Germany.
    Rathmann W; Strassburger K; Tamayo T; Kostev K
    Prim Care Diabetes; 2012 Apr; 6(1):47-52. PubMed ID: 22099215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.
    Wheeler S; Moore K; Forsberg CW; Riley K; Floyd JS; Smith NL; Boyko EJ
    Diabetologia; 2013 Sep; 56(9):1934-43. PubMed ID: 23797633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients.
    Suh DC; Lee DH; McGuire M; Kim CM
    Curr Med Res Opin; 2011 Aug; 27(8):1623-33. PubMed ID: 21696266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy.
    Hazel-Fernandez L; Xu Y; Moretz C; Meah Y; Baltz J; Lian J; Kimball E; Bouchard J
    Curr Med Res Opin; 2015; 31(9):1703-16. PubMed ID: 26154837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic response to newly initiated diabetes therapies.
    Karter AJ; Moffet HH; Liu J; Parker MM; Ahmed AT; Go AS; Selby JV
    Am J Manag Care; 2007 Nov; 13(11):598-606. PubMed ID: 17988185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained hyperglycemia among patients with diabetes: what matters when action is needed?
    Lafata JE; Dobie EA; Divine GW; Ulcickas Yood ME; McCarthy BD
    Diabetes Care; 2009 Aug; 32(8):1447-52. PubMed ID: 19638524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.
    Wu H; Liu J; Lou Q; Liu J; Shen L; Zhang M; Lv X; Gu M; Guo X
    Medicine (Baltimore); 2017 Sep; 96(35):e7533. PubMed ID: 28858080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.